Parker-Hannifin Capitalized research and development increased by 18.1% to $172.00M in Q2 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Capitalized research and development shows an upward trend with a 36.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase reflects ongoing investment in R&D that is being capitalized for tax purposes, potentially signaling future innovation.
This represents the tax benefit associated with research and development costs that have been capitalized rather than ex...
Relevant for companies with high R&D intensity, particularly in aerospace and advanced industrial sectors.
other_deferred_tax_assets_capitalized_research_and_development| Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|
| Value | $92.19M | $145.70M | $172.00M |
| QoQ Change | — | +58.0% | +18.1% |
| YoY Change | — | +58.0% | +18.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.